Home » Topics » BioWorld Science

BioWorld Science
RSS

Taisho isolates FD-594 from Streptoverticillium

April 26, 1996

Preclinical results for DC101 presented at AACR

April 26, 1996

Repligen terminates rPF4 development agreement

April 26, 1996

GVAX cleared to enter phase III testing

April 26, 1996

Antiandrogen research at Roussel Uclaf

April 26, 1996

Mitsubishi in-licenses anti-HER2, will begin clinical evaluation soon

April 26, 1996

Topotecan approval recommended

April 26, 1996

Prograf approved for new indication in Japan, launched in France

April 26, 1996

MitoExtra enters clinical trials

April 26, 1996

Positive results reported in AllerVax Ragweed trials

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...